Delivery Order SPE2DB25D3018-SPE2DB25FUYLF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,599.85 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. MULTAQ is a cardiac arrhythmia medication used to treat atrial fibrillation, reflecting the Defense...
- The Defense Logistics Agency awarded a $1,529.88 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was competitively procured with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 4, 2025, with a ceiling value of $40,373.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,865.37 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-unit quantity), with performance in Conshohocken, Pennsylvania and completion by September 2, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. MULTAQ is an antiarrhythmic...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,801.61 for 60-count tablets of MULTAQ 400 mg, a pharmaceutical product used in cardiac arrhythmia management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed price terms. This delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.26 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-unit count). This firm fixed price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,256.00 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count supply) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $11,496.80 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery by August 6, 2025, and performance will occur at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG tablets (60-count packages) valued at $2,931.72. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- This is a $13,456.14 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of July 31, 2024 and does not have a set-aside designation. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYLFDelivery Order
The Defense Logistics Agency awarded a $4,031.84 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is an antiarrhythmic medication used in the treatment of atrial fibrillation, consistent with AmerisourceBergen's role as a primary pharmaceutical supplier for federal military and healthcare systems. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As the prime contractor on this comprehensive pharmaceutical supply vehicle, AmerisourceBergen provides a full range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's demonstrated capability to fulfill diverse federal pharmaceutical procurement requirements through competitive contracting positions it as a critical vendor in the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/2/25 |